S(A)NDS Template
Module 1 Sections
Module 3 Sections
Submission Class
Abbreviations
100

The name or entity under which the drug submission is filed 

What is the Sponsor/Manufacturer?

100

Found in Mod 1.0.1

What is the Cover Letter?

100

Mod 3 structure, the "S" and "P" stand for this

What is Drug "Substance" and Drug 'Product"?

100

A change in DS manufacturer

What is a C&M Only?

100

RPMD

What is the Regulatory Project Management Division?

200

This table is required for supplemental C&M submissions

What is the Summary of Post-Notice of Compliance Quality Changes table?

200

Found in Mod 1.3.1

What is the Product Monograph?

200

P.8

What is DP "Stability"?

200

A change to add a nitrosamine test to the DP specifications

What is C&M Only?

200

PDD

What is the Pharmaceutical Drugs Directorate?

300

This letter allows a sponsor to reference confidential business information from a Master File

What is a Letter of Access?

300

Found in Mod 1.3.6

What is the CPID?

300

P.7

What is the Container Closure System?

300

A new solid oral strength supported by a biostudy 

What is Comp/C&M?

300

MHPD

What is the Marketed Health Products Directorate?

400

These "studies" may be provided as bioavailability, clinical, pharmacodynamics or pharmacokinetic

What are comparative studies?

400

Found in Mod 1.2.6

What are Letters of Access / Authorization

400

R.1.1

What is Executed Production Documents?

400

A new parenteral strength supported by a biowaiver

What is a C&M/LABELLING?

400

PDQD

What is the Prescription Drugs Quality Division?

500

This Canadian specific document provides a condensed summary of key Quality information

What is the CPID?

500

Found in Mod 1.4.2

What is the CS:BE?

500

P.2

What is the Pharmaceutical Development?

500

Change in the storage conditions for diluted or reconstituted product

 

What is a C&M/LABELLING?

500

IVIVC

What is in-vivo, in-vitro correlation?